000 | 01504 a2200385 4500 | ||
---|---|---|---|
005 | 20250514184225.0 | ||
264 | 0 | _c20040615 | |
008 | 200406s 0 0 eng d | ||
022 | _a1120-009X | ||
024 | 7 |
_a10.1179/joc.2004.16.1.13 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchito, G C | |
245 | 0 | 0 |
_aComparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PROTEKT surveillance study. _h[electronic resource] |
260 |
_bJournal of chemotherapy (Florence, Italy) _cFeb 2004 |
||
300 |
_a13-22 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetamides _xpharmacology |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aAnti-Infective Agents _xpharmacology |
650 | 0 | 4 | _aDrug Resistance, Bacterial |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKetolides |
650 | 0 | 4 | _aLinezolid |
650 | 0 | 4 |
_aMacrolides _xpharmacology |
650 | 0 | 4 |
_aOxazolidinones _xpharmacology |
650 | 0 | 4 |
_aPneumococcal Infections _xdrug therapy |
650 | 0 | 4 | _aPopulation Surveillance |
650 | 0 | 4 |
_aStreptococcus pneumoniae _xdrug effects |
650 | 0 | 4 |
_aVancomycin _xpharmacology |
700 | 1 | _aMarchese, A | |
700 | 1 | _aElkharrat, D | |
700 | 1 | _aFarrell, D J | |
773 | 0 |
_tJournal of chemotherapy (Florence, Italy) _gvol. 16 _gno. 1 _gp. 13-22 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1179/joc.2004.16.1.13 _zAvailable from publisher's website |
999 |
_c14792247 _d14792247 |